Target intelligence / Profile preview

Ribosomal protein L34 pseudogene 8 (RPL34P8)

Target
RPL34P8
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L34 pseudogene 8 (RPL34P8) is a non-functional pseudogene that is homologous to the ribosomal protein L34 (RPL34) gene. While RPL34 encodes a structural component of the large (60S) ribosomal subunit essential for protein biosynthesis, RPL34P8 is a processed pseudogene—it does not encode a functional protein. Pseudogenes like RPL34P8 are common byproducts of the evolutionary history of ribosomal protein genes; they are classified as genomic sequences similar to active genes but lack the capability to produce functional products due to the accumulation of disabling mutations or lack of regulatory elements[2][3][5][8]. Consequently, RPL34P8 has no known biological function, disease association, or therapeutic relevance and is not considered a drug target. All functional, structural, and disease information applies to the parental gene, RPL34, and not to RPL34P8, which lacks protein-coding capacity and fundamental biological activity[2][3][5][8]. Presence in gene lists is mostly incidental for pseudogenic annotation and has no therapeutic or mechanistic significance. RPL34P8 is a processed pseudogene related to the ribosomal protein L34 gene, not a receptor or therapeutic target, and has no direct biological, pharmacological, or disease relevance[2][3][5][8].

Other names
RPL34_5_265RPL34P8

Beyond the preview

Go deeper on Ribosomal protein L34 pseudogene 8 (RPL34P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L34 pseudogene 8 (RPL34P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call